About Us
Markets
Research
Services
NRI Corner
Fund Transfer
Select Link
MF Back Office-SB
MF Back Office-Client
Back Office - Client
Back Office - Sub Brokers
Backoffice – Family Login
Webmail
SPEEDe Login
BSE STAR MF
Branch Login
Create Account
About Us
Markets
Research
Services
Portfolio
NRI Cornor
Fund Transfer
Company Snapshot
Read it, Learn it and Do it for your investment Needs
Equity
Derivatives
Currency
Mutual Fund
IPO
Daily market Tracker
Market Analysis
News Analysis
Company profile
Corporate Actions
Other Market
ETF market Watch
Daily market Tracker
Daily market Tracker
Market Analysis
News Analysis
Company profile
Corporate Actions
Other Market
ETF market Watch
Get Quotes
Company Snapshot
Company Background
Board Of Directors
Peer Comparison
Technicals
+12 more
Score Board
Directors Report
MF Holding
Charts
Company News
History
Monthly High Low
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Deliverable Volumes
Share Holdings Pattern
Bonus Issue
Demergers
Dividend
Mergers
Right Issues
Split Of Facevalue
Company Profile
Get Quotes
Company Snapshot
Company Background
Board Of Directors
Peer Comparison
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Share Holdings Pattern
Charts
Company News
Directors Report
History
MF Holdings
Profit & Loss
Monthly High Low
Technicals
Deliverable Volumes
Bonus Issue
Demergers
Dividend
Mergers
Right Issues
Split Of Facevalue
Company News
Laurus Labs Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:
540222
NSE Symbol:
LAURUSLABS
P/E :
127.55
ISIN Demat:
INE947Q01028
Div & Yield %:
0.1
EPS :
16.15
Book Value:
97.20
Market Cap (Rs. Cr.):
111,304.32
Face Value :
2
Date
Headline
14-Oct-26
Laurus Labs invested Rs 1,078,000,000 for a 49% stake in the KRKA Pharma joint venture
13-Oct-26
Laurus Labs to review financial results and interim dividend at October 29 board meeting
09-Oct-26
Laurus Labs confirms KFin Technologies certified securities details for the September quarter
06-Oct-26
Laurus Labs invested Rs 12 crore to acquire a 26% stake in Kurnool Renewables
25-Sep-26
Laurus Labs will halt securities trading from October 1, 2026, per SEBI regulations
10-Jul-26
Laurus Labs schedules board meeting
04-Jun-26
Laurus Labs allots 3.93 lakh equity shares under ESOP
30-Apr-26
Board of Laurus Labs recommends Second Interim dividend
10-Apr-26
Laurus Labs to hold board meeting
09-Jan-26
Laurus Labs to declare Quarterly Results
Prev
1
2
3
Next